Osteoporosis-;weakening of the bones with age-;affects millions worldwide, and this figure is increasing annually as the global population ages.
RegenxBio touts positive data for rare disease drug RGX-121 – Pharmaceutical Technology
RGX-121 is a gene therapy designed to deliver a functional copy of the IDS gene to the central nervous system via the NAV AAV9 vector.